Reverse Takeover in United States.
How a private company in United States can go public in the United States by reverse takeover into a clean Nasdaq, NYSE American or OTC shell — and the home-market considerations that shape the transaction.
For a US private company, the reverse takeover is not a cross-border manoeuvre — it is a domestic alternative to the traditional IPO. Instead of assembling an underwriting syndicate and marketing a priced offering, a private operating business merges into an existing public shell already registered with the Securities and Exchange Commission, and its shareholders emerge in control of a listed company.
That distinction shapes everything on this page. There is no offshore holding company to build, no foreign-exchange approval to clear, and no currency mismatch to manage. What remains is the domestic core: SEC reporting, US-standard audits, and the listing standards of Nasdaq, NYSE American, or the OTC Markets.
- Conduct thorough diligence on the shell — reporting currency, undisclosed liabilities, legacy shareholders, and any custodianship or reinstatement history.
- Plan a concurrent or follow-on financing, since the reverse merger provides a quote rather than fresh capital.
- Upgrade historical financials to PCAOB-audited, US GAAP standard across the required comparative periods before closing.
- Build the internal controls and reporting discipline needed to meet ongoing SEC and exchange obligations post-merger.
- Confirm the target venue's listing standards, including Nasdaq's US$4.00 minimum bid, before selecting Nasdaq, NYSE American, or the OTC.
United States at a glance
| Home market | Nasdaq, NYSE, NYSE American, and the OTC Markets |
|---|---|
| Home regulator | Securities and Exchange Commission (SEC) |
| Currency | US dollar (USD) |
| Notable sectors | Technology, healthcare and biotech, energy, consumer, and industrials. |
| US venues | Nasdaq, NYSE American, and the OTC Markets (OTCQX, OTCQB) |
| Our role | Advisory and arranger of the reverse takeover; not a broker-dealer, law firm or auditor. |
Why United States companies list in the United States
American companies choose a reverse takeover for reasons of speed, control, and certainty rather than access. A conventional IPO exposes a company to market-window timing, syndicate economics, and pricing set by the book; a reverse merger is instead governed largely by diligence, disclosure preparation, and the terms negotiated with the shell. The result is a public quote that can serve as an acquisition currency, a liquidity path for early investors and employees, and a platform for raising public capital over time. For founders who want to reach public markets on a defined timetable — or who operate in a sector where the IPO window is narrow — the RTO offers a structured route to the same end without surrendering the process to underwriter scheduling.
The United States market and a US listing
The United States is the destination, not a stepping stone, so the comparison here is between routes rather than markets: an underwritten IPO versus a reverse takeover onto Nasdaq, NYSE, NYSE American, or the OTC Markets, all under SEC oversight. An IPO can deliver a large primary raise and a marketing halo, but at the cost of time, expense, and window risk. A reverse takeover typically reaches a listing faster and with more predictable process, though it usually pairs with a separate financing to bring in fresh capital, since the merger itself provides the quote rather than the cash. Choosing between them is a question of objectives, capital needs, and timing, best weighed with experienced advisers.
Sectors driving United States US listings
US reverse takeovers span the breadth of the domestic economy — technology and software, healthcare and biotech, energy, consumer, and industrials all use the route. Growth-stage technology and life-sciences companies value the defined path to a quote when IPO windows are unreliable, while asset-heavy energy and industrial businesses use the public currency to fund consolidation. Because these companies compete for capital directly against listed US peers, the equity story is benchmarked against familiar public comparables from day one, which sharpens positioning and helps an incoming shareholder base assess the business on recognisable terms.
Cross-border structuring from United States
Because the company and the shell are both domestic, the structuring conversation looks entirely different from a cross-border deal. There is no Cayman or BVI holding company to insert, no round-tripping analysis, and no outbound-investment or exchange-control approval to obtain. The central work is instead diligence on the shell itself — confirming it is clean, current in its SEC reporting, free of undisclosed liabilities and legacy shareholder issues, and appropriately capitalised — alongside the mechanics of the merger, the resulting share structure, and control. Careful counsel focus on the shell's reporting history, any custodianship or reinstatement issues, and the terms that determine post-merger ownership. This is educational orientation; the specific transaction should be structured and vetted by experienced US securities counsel.
Audit and reporting readiness
A domestic US company already reports in dollars and, typically, under US GAAP, so there is no IFRS conversion and no foreign-currency remeasurement to manage — a genuine simplification relative to cross-border RTOs. The financial statements must still be audited by a PCAOB-registered firm and presented for the comparative periods that SEC rules and the target venue require. For a private company that has not previously carried public-company audits, upgrading historical financials to the required standard, and building the controls to sustain ongoing reporting, is usually the critical-path item and the work worth starting first.
Choose a US venue
The same United States company can target different US venues depending on its size and readiness. Each page below sets out the route and the listing standards.
- Nasdaq listingUnited States → Nasdaq
- NYSE American listingUnited States → NYSE American
- OTC Markets listingUnited States → OTC Markets
Exploring a US listing from Tell us about your company.
Start an enquiry →Reverse Takeover in United States — frequently asked questions
Q1How does a US reverse takeover compare with a traditional IPO?
A reverse takeover merges a private company into an existing SEC-reporting shell, reaching a public quote on a more defined timetable than an underwritten IPO. It avoids window and syndicate risk but usually pairs with a separate financing, since the merger provides the listing rather than the cash.
Q2Do domestic companies need an offshore holding structure?
No. Because both the company and the shell are US-domiciled, there is no Cayman or BVI layer, no round-tripping analysis, and no exchange-control approval. The structuring focus shifts to diligence on the shell and the terms of the merger itself.
Q3What is usually the hardest part for a US company?
Typically the financial statements. A private company must present PCAOB-audited, US GAAP financials for the required comparative periods and build controls for ongoing reporting. Upgrading historical accounts to public-company standard is usually the critical-path item, so it is worth starting first.
Q4Is Reverse Takeover a broker-dealer?
No. Reverse Takeover is an advisory and arranger — not a registered broker-dealer, investment adviser, law firm or audit firm. Regulated work is performed by the US securities counsel, PCAOB-registered auditors and transfer agents we coordinate.
Related markets
This page is general, educational information about listing routes and is not investment, legal, tax, or accounting advice, nor an offer or solicitation. Regulatory details change and vary by circumstance; obtain advice from qualified US securities counsel and your home-market advisers. See our disclosures.